<DOC>
	<DOCNO>NCT00969865</DOCNO>
	<brief_summary>This study evaluate effectiveness individualized approach diagnose and/or treat atherosclerosis . This do combining genetic information , lifestyle information , participant education , image test track diagnosis , therapy , treatment two group : 1 ) Standard Management Group ( diagnose and/or treat accord standard care ) 2 ) Individualized Management Group ( standard care plus genetic testing coronary artery calcium scan ) .</brief_summary>
	<brief_title>Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program</brief_title>
	<detailed_description>The purpose proposal create large , community-based demonstration project evaluate value highly individualized approach atherosclerosis risk reduction . In project set compare delivery appropriate therapy resource utilization use current national guideline management atherosclerosis compare use highly individualize approach atherosclerosis risk reduction , base evaluation specific feature individual tailor management base evaluation . We plan show utilizing iCARE Program , patient receive appropriate diagnosis subsequent therapy efficient manner .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>No known coronary artery disease prior coronary disease cardiac catheterization ( â‰¤39 % major epicardial vessel ) prior myocardial infarction prior STelevation myocardial infarction ( 1 mm STelevation 2 contiguous lead ) prior nonSTelevation myocardial infarction ( CKMB &gt; 2x ULN elevate troponin indicative myocardial necrosis base local institutional cutpoints ) prior coronary revascularization procedure Intermediate high Framingham Risk Score ( 10year risk 10 % great ) Ability willingness provide consent Authorization use PHI Presence know cardiomyopathy Presence permanent pacemaker , defibrillator , CRT device Presence clinically significant , uncontrolled arrhythmia ( chronic paroxysmal atrial fibrillation NOT exclusion . Arrhythmias treat successfully ablation exclusion . Presence know genetic abnormality cholesterol metabolism ( e.g . familial hypercholesterolemia ) Inability unwillingness adhere follow schedule Inability unwillingness provide inform consent Authorization use PHI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Atherosclerosis</keyword>
</DOC>